The effect of cholesterol-lowering treatment on renal function

被引：15
作者：
Liberopoulos, EN [1 ]
Mikhailidis, DP
Athyros, VG
Elisaf, MS
机构：
[1] Univ London, Royal Free & Univ Coll, Sch Med, Dept Clin Biochem, London, England
[2] Aristotle Univ Thessaloniki, Hipocrat Hosp, Artherosclerosis Unit, Thessaloniki, Greece
[3] Univ Ioannina, Dept Internal Med, Ioannina, Greece
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2006年 / 47卷 / 03期
关键词：
D O I：
10.1053/j.ajkd.2005.11.031
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：561 / 561
页数：1
相关论文
共 10 条
  • [1] The role of statins in chronic kidney disease
    Agarwal, R
    Curley, TM
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 330 (02) : 69 - 81
  • [2] The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
    Athyros, VG
    Mikhailidis, DP
    Papageorgiou, AA
    Symeonidis, AN
    Pehlivanidis, AN
    Bouloukos, VI
    Elisaf, M
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (07) : 728 - 734
  • [3] Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
    Athyros, VG
    Elisaf, M
    Papageorgiou, AA
    Symeonidis, AN
    Pehlivanidis, AN
    Bouloukos, VI
    Milionis, HJ
    Mikhailidis, DP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : 589 - 599
  • [4] Statins and renal function
    Elisaf, M
    Mikhailidis, DP
    [J]. ANGIOLOGY, 2002, 53 (05) : 493 - 502
  • [5] Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on renal function
    Epstein, M
    Campese, VM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) : 2 - 14
  • [6] Kasiske B L, 1991, Adv Nephrol Necker Hosp, V20, P109
  • [7] The effect of cholesterol reduction with cholestyramine on renal function
    Kshirsagar, AV
    Shoham, DA
    Bang, H
    Hogan, SL
    Simpson, RJ
    Colindres, RE
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (05) : 812 - 819
  • [8] Apolipoprotein E and renal disease
    Liberopoulos, E
    Siamopoulos, K
    Elisaf, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (02) : 223 - 233
  • [9] Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients
    Tonolo, G
    Melis, MG
    Formato, M
    Angius, MF
    Carboni, A
    Brizzi, P
    Ciccarese, M
    Cherchi, GM
    Maioli, M
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (11) : 980 - 987
  • [10] Does lipid-lowering therapy slow progression of chronic kidney disease?
    Wheeler, DC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (05) : 917 - 920
1